FindTrial
Sign In

A clinical trial for mid trimester abortion using mifepristone and misoprostol with & without foleys catheter

A randomized contolled trial for mid trimester abortion using mifepristone and misoprostol with & without Foleys catheter

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/030077
Enrollment
60
Registered
2020-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O048- (Induced) termination of pregnancywith other and unspecified complications

Interventions

Intervention1: Medical vs Mechanical method of induction: one group will receive tab mifepristone 200mg followed by misoprostol 200 mcg every 4 hourly ( maximum of 5 doses) second group will receive

Sponsors

Department of OBG
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Singleton pregnancy

Exclusion criteria

Exclusion criteria: 1) Incomplete or inevitable abortion 2) renal failure, adrenal insufficiency, liver failure, cardiovascular diseases, respiratory distress 3) blood clotting disorder or on anticoagulant therapy 4) Anemia Hb 5) any history suggestive of drug and latex allergy

Design outcomes

Primary

MeasureTime frame
induction abortion intervalTimepoint: induction abortion interval within 12 hours 12 to 24 hours 24 to 36 hours 36 to 48 hours—

Secondary

MeasureTime frame
1 Spontaneous expulsion of foleys catheter 2 Need of oxytocin infusion complete abortion 3 Need for suction and evacuationTimepoint: 12 hours of foleys catheter—

Countries

India

Contacts

Public ContactDr CD Sharma

Dr Rajnendra Prasad Government Medical College Kangra At Tanda

cdsharma2006@gmail.com9816326544

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 10, 2026